A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP

PHASE3CompletedINTERVENTIONAL
Enrollment

598

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 4, 2017

Study Completion Date

May 15, 2017

Conditions
Community-acquired Pneumonia
Interventions
DRUG

Nemonoxacin

DRUG

Levofloxacin

Trial Locations (63)

200040

Institute of Antibiotics, Huashan Hospital, Fundan University, Shanghai

Unknown

Baotou Central Hospital, Baotou

Aerospace Center Hospital, Beijing

Affiliated Beijing Anzhen Hospital of Capital Medical University, Beijing

Affiliated Beijing Chaoyang Hospital of Capital Medical University, Beijing

Chinese People's Liberation Army General Hospital, Beijing

Institute of Clinical Pharmacology, Peking University, Beijing

Peking University People's Hospital, Beijing

Changsha Central Hospital, Changsha

The Third Changsha Hotpital, Changsha

The Third Xiangya Hospital of Central South University, Changsha

Daping Hospital, Chongqing

Guangxi Zhuang Autonomous Region People's Hospital, Guangxi

First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Guilin Medical School Affiliated Hospital, Guilin

Hainan General Hospital, Haikou

Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital of Zhejiang University, Hangzhou

The First Hospital of Anhui Medical University, Hefei

The Affilated Hospital of Inner Mongolia Medical University, Hohhot

The First Hospital of Jilin University, Jilin

The Fourth Hospital of Jilin University, Jilin

Jinan Central Hospital, Jinan

The Second Hospital of Shandong University, Jinan

Gansu Provincial People's Hospital, Lanzhou

Jiangxi Provincial People's Hospital, Nanchang

Second Subsidiary Hospital of Nanchang Medical College, Nanchang

General Hospital of Nanjing Military Command, Nanjing

Huadong Hospital Affiliated to Fudan University, Shanghai

Shanghai East Hospital of Tongji University, Shanghai

Shanghai Pulmonary Hospital, Shanghai

General Hospital of Shenyang Military, Shenyang

Shengjing Hospital, Shenyang

Shenzhen People's Hospital, Shenzhen

The Second People's Hospital of Shenzhen, Shenzhen

General Hospital of Chengdu Military Region, Sichuan

West China Center of Medical Sciences of Sichuan University, Sichuan

First Hospital of Shanxi Medical University, Taiyuan

Wuxi People's Hospital, Wuxi

Tangdu Hospital, Xi'an

The First Affilated Hospital of Xiamen University, Xiamen

Northern Jiangsu People's Hospital, Yangzhou

The First Affiliated Hospital,College of Medicine,Zhejiang University, Zhejiang

Changhua Christian Hospital, Chang-hua

Chiayi Chang Gung Memorial Hospital, Chiayi City

NTUH Hsin-Chu Branch, Hsinchu

Hualien Tzu Chi Hospital, Hualien City

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Kaohsiung Veterans General Hospital, Kaohsiung City

Keelung Chang Gung Memorial Hospital, Keelung

Far Eastern Memorial Hospital, New Taipei City

MacKay Memorial Hospital, New Taipei City

China Medical University Hospital, Taichung

Chung Shan Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

Chi Mei Hospital, Liouying, Tainan City

National Taiwan University Hospital, Taipei

Taipei Medical University - Shuang Ho Hospital, Taipei

Taipei Medical University Hospital, Taipei

Taipei Municipal Wanfang Hospital, Taipei

Tri-Service General Hospital, Taipei

NTUH Yun-Lin Branch, Yuli

All Listed Sponsors
lead

TaiGen Biotechnology Co., Ltd.

INDUSTRY

NCT02205112 - A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP | Biotech Hunter | Biotech Hunter